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Abstract
Background In the United Kingdom, nurses and pharmacists who
have undertaken additional post-registration training can prescribe
medicines for any medical condition within their competence (non-
medical prescribers, NMPs), but little is known about patients’
experiences and perceptions of this service.
Objective to obtain feedback from primary care patients on the
impact of prescribing by nurse independent prescribers (NIPs) and
pharmacist independent prescribers (PIPs) on experiences of the
consultation, the patient–professional relationship, access to medi-
cines, quality of care, choice, knowledge, patient-reported adher-
ence and control of their condition.
Design Two cross-sectional postal surveys.
Setting and participants Patients prescribed for by either NIPs or
PIPs in six general practices from diﬀerent regions in England.
Results 30% of patients responded (294/975; 149/525 NIPs; 145/
450 PIPs). Most said they were very satisﬁed with their last visit
(94%; 87%), they were told as much as they wanted to know
about their medicines (88%; 80%), and felt the independent pre-
scriber really understood their point of view (87%; 75%). They
had a good relationship with (89%; 79%) and conﬁdence in (84%;
77%) their NMP. When comparing NMP and doctor prescribing
services, most patients reported no diﬀerence in their experience of
care provided, including access to it, control of condition, support
for adherence, quality and safety of care.
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Discussion and conclusions Patients had positive perceptions and
experience from their NMP visit. NMPs were well received, and
patients’ responses indicated the establishment of rapport. They
did not express a strong preference for care provided by either
their non-medical or medical prescriber.
Introduction
The expansion of non-medical prescribing in
the United Kingdom (UK) formed part of a
wide ranging programme to ‘modernize’ the
National Health Service (NHS).1 For patients,
the stated aims of non-medical prescribing pol-
icy were to improve quality of care, patient
choice, knowledge, adherence and access to
medicines whilst maintaining safety. Following
early development of prescribing by commu-
nity nurses (health visitors and district nurses)
in the 1990s, the scope of nurse independent
prescribing from a restricted list of medicines
was gradually widened. In the next phase,
nurses and, for the ﬁrst time, pharmacists, were
authorized to prescribe as part of continuing
care for patients with long-term conditions pre-
viously diagnosed by a doctor (‘Supplementary
prescribing’). These changes culminated in
2006 with the introduction of nurse and phar-
macist independent prescribing of any medicine
for any medical condition within their compe-
tence, including some controlled drugs (under
the misuse of drugs legislation) for speciﬁed
medical conditions (nurses only). Non-medical
prescribing is also developing internationally,
and the UK independent prescribing model is
arguably the most radical.2,3
Prior to the study reported here, several liter-
ature reviews and national evaluations of nurse
independent prescribing (NIP) from a restricted
formulary and pharmacist supplementary pre-
scribing had reported positively on patient
views. In particular, characteristics such as
longer consultations and more in-depth discus-
sion to address any questions and concerns
were especially valued by patients.4–8 Patients
of nurse and pharmacist supplementary pre-
scribers perceived that their non-medical pre-
scriber (NMP) had particular expertise in the
clinical condition for which they were being
seen.6 Nurse and pharmacist supplementary
prescribers were also viewed as more approach-
able than doctors and many patients reported
ﬁnding it easier to get an appointment with
their NMP than with their doctor.6 However,
it was also reported that some patients, espe-
cially those reporting poorer health, would
have liked to have spent more time with nurse/
midwife prescribers.8
Although the picture is in the main positive
from published studies, a number of ﬁndings
within them are suggestive of some diﬀerential
patient preferences that required further inves-
tigation. For example, a theoretical study with
‘future patients’ concluded that one in ten
patients said they would prefer to see a doctor
rather than a nurse prescriber.9 Other research
with patients of nurse or pharmacist prescrib-
ers also found that some would prefer to see a
doctor.6,7,10. However, all of these studies were
conducted prior to the 2006 changes in NMP.
At the time of this research, published stud-
ies with a focus on patients’ views were con-
cerned with previous models of non-medical
prescribing and reported little evidence relating
to outcomes such as adherence or impact on
condition management.11–14 Furthermore, the
scarce evidence on patient experiences of inde-
pendent prescribing by pharmacists was based
on patients’ general feedback rather than relat-
ing to the management and control of speciﬁc
conditions. The study reported here was part
of a larger patient-centred evaluation of nurse
and pharmacist independent prescribing incor-
porating patient views into research conducted
to inform future policy decision-making.15 The
originality of our research lay in the fact that
we gathered evidence on patient views after the
2006 extension of the scope of NMP services,
and using novel self-reported patient outcome
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measures including adherence, or impact on
condition management. Its objective was to
obtain patient views on their experiences of
their consultation with the NMP, access to
medicines, quality of care, knowledge about,
and adherence to, medicines, patient–profes-
sional relationship and their reports on the
control of their condition under non-medical
prescribing.
Method
Two cross-sectional postal surveys of patients
consulting with either nurse independent pre-
scribers (NIPs) or pharmacist independent pre-
scribers (PIPs) prescribing in general practice
settings in primary care were conducted.
Questionnaire development
The questionnaire design drew upon previous
literature (in particular, two surveys of patients
under the care of nurse and pharmacist supple-
mentary prescribers).6,11 The current study
focuses on independent rather than supplemen-
tary prescribing, but the principles are suﬃ-
ciently relevant and applicable to be
transferable. The existing surveys included spe-
ciﬁc questions on quality of care, patients’
experiences of their consultation and knowl-
edge of their medicines. Additional questions
were designed covering clinical outcomes,
access to medicines, and adherence.
NIPs and PIPs may prescribe for both long-
term and acute conditions and elsewhere in the
evaluation a national survey showed that PIPs
were prescribing mainly for long-term condi-
tions, whilst NIPs were prescribing for both
acute and long-term conditions.13 The current
study focused on long-term conditions to
enable investigation of adherence and clinical
outcomes (represented here by patient reports
of how well their condition was controlled).
The questionnaire was structured in four sec-
tions: (i) patient characteristics (including gen-
der, age, ethnic background), number of
previous consultations with the same NIP or
PIP, reason for most recent consultation; (ii)
views and experiences relating to the most
recent consultation with the NIP or PIP; (iii)
views and experiences of access to, and quality
of, and adherence to, care from the NMP; and
(iv) comparing the NIP or PIP with the doctor
in relation to safety and quality of care, access
to medicines, knowledge, clinical outcome (self-
reported adherence and control of condition)
and patient–professional relationship. There
were 27 questions in total (10 from the Stewart
et al. survey, 9 from Bissell et al. and 8
new).5,11,12 In sections ii) and iii), information
was collected using 15 items structured on a 5-
point Likert scale (from strongly agree to
strongly disagree), whilst in section iv) for each
of the 12 statements respondents had to choose
between NMP, doctor or no diﬀerence between
professionals. Two versions of the question-
naire were produced with speciﬁc wording
relating to either NIP or PIP.
Sample
The case study sites and NMPs – The wider
evaluation study included six general practice
case study sites selected from six diﬀerent Stra-
tegic Health Authorities (SHA) of England to
reﬂect the clinical areas in which NIPs and
PIPs had most frequently reported prescribing
in the national survey carried out as part of
the evaluation. These clinical conditions, for
which the case study site NMPs (ﬁve NIPs and
ﬁve PIPs) reported prescribing most frequently,
were asthma (NIPs and PIPs), diabetes (NIPs)
and secondary prevention in coronary heart
disease (CHD; PIPs). Patients involved in the
survey (see below) could also present with
other conditions. Five of the six sites had either
NIPs or PIPs, and one (Site 5) had both and
was the only site where patients might have
experienced care from the two diﬀerent NMP
types, although the patient was not explicitly
asked whether he/she had been exposed to
both types of NMP. More details on the case
study sites are reported in Table 1.
The patients – A sample of patients’ records
from the NIP or PIP’s caseload was drawn
from the practice’s clinical system and ordered
© 2013 John Wiley & Sons Ltd
Health Expectations, 18, pp.1241–1255
Survey of patients’ experiences and perceptions of care, M Tinelli et al. 1243
either consecutively according to their booking
time or alphabetically. Records were then
selected if there was prescribing by a NIP/PIP
in the last 12 months (any condition) until the
target number for each site was met. Since the
target number for analysis was approximately
250 returned questionnaires (125 from each
survey to allow for comparison across sub-
groups, see data analysis), a total of 975 ques-
tionnaires (525 to patients of NIPs and 450 to
patients of PIPs) were posted to reﬂect a con-
servative 25% response rate estimate15,16. Dif-
ferences in the number of participating patients
between NIP and PIP surveys lay in the fact
that participating sites presented a variation in
caseloads, and the number of surveys posted
out from each reﬂected this.
Ethics approval
Ethical approval was applied for and granted
by a NHS Research Ethics Committee Dorset
REC (Ref No 08/H0201/163), and NHS
Research Governance approval was applied for
and received in each of the research site areas.
There were some diﬀerences between the
approvals, conditions and requirements of the
NHS Research & Development (R & D) orga-
nizations in diﬀerent areas. Some declined to
give permission for the researcher to have
access to patient contact details, necessitating
diﬀerent arrangements for data collection in
some practices.
Piloting the questionnaire
The draft questionnaire was reviewed by two
patient representatives, and some changes were
made to question wording. The questionnaire
was then piloted with 15 patients at two sites
(these patients were not included in the main
study). Respondents were also asked to com-
plete a pro forma which asked about the ease
of completion, ease of understanding, length of
the survey and conﬁdentiality (extent to which
patients felt able to answer the questions hon-
estly), with space for comments or suggestions.
Based on the responses to the pilot, no further
changes to the questionnaire were found to be
necessary.
Data collection
The questionnaires were sent by post (between
October and December 2009) with a reply paid
return envelope. They were coded to identify
the research site, and the NIP and PIP versions
were printed on diﬀerent coloured paper to
Table 1 Participating site characteristics
Site 1 Site 2 Site 3 Site 4 Site 5 Site 6
Most common area
of prescribing
Hypertension Infections Hypertension Hypertension Asthma Family
Planning
2nd most common
area of prescribing
Coronary heart
disease (CHD)
prevention
Asthma CHD prevention CHD prevention Chronic
obstructive
pulmonary
disease
(COPD)
Diabetes
Number of patients
prescribed
for per week
31–40 41–50 <5 21–30 11–20 51+
Number of items
prescribed per
week
41–50 41–50 21–30 21–30 31–40 51+
Multiple non-medical
prescribers
Yes No Yes Yes No Yes
Strategic Health
Authority (SHA)
South Central East of England West Midlands London East of England North West
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enable sorting by site and practitioner type.
Sampling and mailings were done by practice
staﬀ (briefed by the researcher) in some sites
and the researcher in the others depending on
local NHS R & D policy. Due to diﬀering local
NHS research governance policies, it was not
possible to conduct follow-up mailings across
all sites and so a single mailing was sent.
Entering and checking data
Fourteen returned questionnaires were found
to have missing responses for between one and
four questions. Following discussion, they were
included in the analysis as the number of miss-
ing responses was low. In thirteen question-
naires, respondents gave multiple answers to
one or more questions and questions with dou-
ble answers were coded as missing data. Data
were entered into a Survey Monkey data form
designed for the questionnaire with a 10%
accuracy check.17
Data analysis
Information on responses, respondent charac-
teristics and reasons for the most recent consul-
tation with the NIP or PIP were analysed. For
questions with Likert-type scales, the percent-
age and numbers strongly agreeing/agreeing
were compared with those strongly disagreeing/
disagreeing and are reported separately for
patients of NIPs and PIPs. The full matrices
from both surveys with percentages from all
the ﬁve Likert categories are fully reported
elsewhere (see Supporting information).
Respondents’ comparisons between the services
provided by their NIP or PIP and their doctor
were further investigated. Percentages prefer-
ring the NMP compared with the doctor or no
diﬀerence are reported. Comparisons between
groups are reported looking at (i) overall sam-
ple: NIP or PIP vs. doctor vs. no diﬀerence;
(ii) the subgroup with strong preferences for a
prescriber: NIP or PIP vs. doctor. Because the
two surveys were separate and with diﬀerent
respondents, ﬁndings from the NIP and PIP
questionnaires were not directly comparable,
but it was possible to comment on aggregated
diﬀerences across results.
Frequencies and valid percentages are
reported for the categorical data. Diﬀerences
between groups were tested with chi-squared
statistics. Given the numbers of tests performed
signiﬁcance was considered at 99% (P < 0.01).
Analysis was conducted using SPSS version 16
package.18
Results
Results from the whole sample are reported
below. In total, 30% patients responded (294/
975; 149/525 NIPs group; 145/450 PIPs group).
Responses were collected from three (NIP sur-
vey) and four (PIP survey) sites (see Table 2).
Patients’ characteristics and their reasons for
consulting with the NMP
Characteristics of responding patients are pre-
sented in Table 2. Most patients of NIPs were
females (62% compared with males; P < 0.01),
older than 54 years (67%, P < 0.01) and white
(84%, p not reported for limited sample size).
The proportions of male and female patients of
PIPs were similar (47% vs. 49%; P = 1; 4%
not stated); most were older than 54 years
(82%, p not reported for limited sample size)
and white (86%, p not reported for limited
sample size). In both the NIP and PIP surveys,
the majority of patients had previous experi-
ence of two or more consultations with the
NMP (84%, P < 0.01; 75%, P < 0.01 com-
pared with one consultation or no experience
of NMP).
The most frequent reasonsa for consulting
with the NIP on the most recent occasion were
diabetes (36%; 53/149); chest infection/sinusi-
tis/cold/cough (12%; 18/149) and asthma (8%;
12/149). For PIPs, the most frequent were
hypertension (31%; 45/145); cholesterol (13%;
19/145); heart problems (10%; 14/145); asthma
(8%, 12/145); and general medication review
(6%, 9/145).
aNote that respondents might report more than one reason.
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Perceptions and experiences relating to the
most recent consultation with the NMP
The majority of patients strongly agreed or
agreed (SA/A) that they were very satisﬁed with
their most recent consultation with their NIP
(94% SA/A; P < 0.01) or PIP (87% SA/A;
P < 0.01; see Table 3).b Respondents SA/A
that the NIP or PIP told them as much as they
wanted to know about their medicines (88%
and 80% SA/A; P < 0.01), and that the NMP
had really understood their point of view (87%
and 75% SA/A; P < 0.01). About half of
respondents reported that the independent pre-
scriber asked them what they thought about
their prescribed medicines (49% and 56% SA/
A); P < 0.01 only in PIP survey). Relatively few
wished it had been possible to spend a little
more time with the NIP or PIP (24% and 23%
SA/A; P < 0.01) or agreed that some things
about their consultation with the NIP or PIP
could have been better (13% and 22% SA/A;
P < 0.01). Results are fully reported in Table 3.
Relationship with the independent prescriberc
Respondents reported having a good relation-
ship with their prescribing nurse or pharmacist
Table 2 Responses according to participating sites and patient characteristics
Nurse independent prescriber survey1
Pharmacist independent prescriber
survey
n % P value n % P value
Sites
1 – – NA 54 41.9 NA
2 43 33.3 – –
3 – – 28 21.7
4 41 31.8 23 17.8
5 – – 24 18.6
6 45 34.9 – –
Gender
Male 47 33.3 <0.01 62 47.0 1
Female 87 61.7 65 49.2
Age
34 years and under 14 10.0 <0.01 3 2.3 NA2
35–54 years 29 20.6 18 13.6
55–74 years 66 46.8 80 60.6
75–85 years & over 29 20.9 28 21.2
Ethnic background
White 119 84.4 NA2 114 86.4 NA2
Black 8 5.7 11 8.3
Asian 4 2.8 1 0.8
Mixed 1 0.7 3 2.3
Other 4 2.8 1 0.8
I have consulted this …. ….nurse independent prescriber ….pharmacist independent prescriber
Only once 11 7.8 <0.01 27 20.5 <0.01
Twice 16 11.3 29 22.0
3 or 4 times 34 24.1 26 19.7
5 or more times 69 48.9 44 33.3
1Two NIP survey patients have been miscoded to a PIP only site and therefore deleted from the analysis as we do not know which site they
were from. Their responses are still considered for the other comparisons.
2Limited sample size.
bIn this section P values are for the comparison of strongly
agreed/agreed (SA/A) responses with disagreed/strongly
disagreed (D/SD) for respondents under the care of either
the NIP or PIP.
© 2013 John Wiley & Sons Ltd
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(89% and 79%, respectively SA/A; P < 0.01)
and conﬁdence in them (84% and 77% SA/A;
P < 0.01).c More than half reported being
involved in decisions about the medicines pre-
scribed for them by their independent pre-
scriber (57% and 60%, SA/A; P < 0.01). Full
results are reported in the supporting informa-
tion.
Comparing care received from the independent
prescriber and the doctor
Respondents were asked to compare diﬀerent
aspects of care received from their NIP or PIP
with care from their prescribing doctor, includ-
ing quality and safety of care, support for
adherence, clinical outcomes (reported control
of condition), and access to care and their
medicines. Results are shown in Tables 4–6.
Quality and safety of care
In both the NIP and PIP surveys, a majority
of respondents stated no diﬀerence in the
safety or quality of care received from the
NMP or the doctor (all group comparison,
P < 0.01; see Table 4).c However, there were
some diﬀerences among the small subgroups of
patients, with a stronger preference for either
the NMP or doctor option. Here, patients of
both NIPs and PIPs were signiﬁcantly more
likely to prefer the doctor’s option for safety of
care, and patients of PIPs were also signiﬁ-
cantly more likely to do so for quality of care
(see Table 4).
Support for adherence
The 10 items reporting on support for adher-
ence (see Table 5) were from two diﬀerent
question types.
The ﬁrst set of questions (the ﬁrst two items
of Table 5) used Likert-type scales, where the
percentage and numbers SA/A were compared
with those SD/D. When asked whether they
were more likely to take their medicines when
Table 3 Perceptions and experiences relating to the most recent consultation with the NMP
Nurse independent prescriber survey
Pharmacist independent prescriber
survey
Number of SA/A %
SA/A vs. SD/D
P value Number of SA/A %
SA/A vs. SD/D
P value
I was very satisfied with my visit to
this independent prescriber
133 94.3 <0.01 115 87.1 <0.01
This independent prescriber told me
as much as I wanted to know about
my medicines
124 87.9 <0.01 105 79.5 <0.01
Some things about my consultation
with the independent prescriber
could have been better
18 12.8 <0.01 29 22.0 <0.01
I felt the independent prescriber
really understood my point of view
123 87.2 <0.01 99 75.0 <0.01
I wish it had been possible to spend
a little more time with the
independent prescriber
34 24.1 <0.01 30 22.7 <0.01
The independent prescriber asked me
what I thought about my prescribed
medicines
69 48.9 0.03 74 56.1 0.01
SA, strongly agree; A, agree; D, disagree; SD, strongly disagree. The full data matrices (including data on NS = not sure) are available
elsewhere (see supporting information). P values are for the comparison of SA/A responses with D/SD for respondents under the care of
either the NIP or PIP.
cIn this section P values report on comparisons between: (i)
NIP (or PIP) vs. doctor vs. no diﬀerence: All groups; (ii)
the subgroup with strong preferences for a prescriber: NIP
(or PIP) vs. doctor.
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they were prescribed by their NIP or PIP, the
majority strongly agreed/agreed (82% and
79% SA/A; P < 0.01).
The second set of questions (remaining 8
items of Table 5) asked the respondent to com-
pare the services provided by their NIP or PIP
and their doctor and reported on three separate
options (independent prescriber, doctor and no
diﬀerence)c. In response to statements relating
to aspects of consultations with prescribers that
might impact on non-adherence, in most cases
respondents did not did report a diﬀerence in
their experience of care between either an NMP
or prescribing doctor, although there were some
signiﬁcant diﬀerences among the subgroups with
a stronger preference for either NMP or doctor
option.
In the NIP survey, patients were more likely
to report being asked by the NIP compared
with the doctor about how they could ﬁt medi-
cines into their routine (24% vs. 11%,
P < 0.01). More patients of NIPs reported they
were likely to be told how a new medicine would
help them (31% vs. 17%; P = 0.02) by their
NIP in comparison with a doctor, but this did
not reach signiﬁcance at 0.02. Patients also
reported they were more likely to be told about
the possible side eﬀects of a new medicine by the
doctor than by the NIP, but this did not reach
signiﬁcance either (30% vs. 16%; P = 0.02).
In the PIP survey, the majority of respon-
dents stated no diﬀerence in care received from
either PIP or doctor for the likelihood of being
asked about how they could ﬁt medicines into
their routine (48% no diﬀerence vs. 24% higher
from PIP vs. 28% higher from doctor;
P < 0.01) and for the likelihood of being
advised about non-drug treatments for their con-
dition/s (51% no diﬀerence vs. 20% higher
from PIP vs. 29% higher from doctor;
P < 0.01).
Control of condition
When asked about control of their condition,
the majority SA/A that being treated by their
NIPs or PIPs had no eﬀect on their condition
(46% and 44%; signiﬁcant in the NIP survey
only P = 0.03; see Table 6).
Access to carec
Fewer than half of patients of both NIPs and
PIPs SA/A that they had longer appointments
with their NMP compared with their doctor
(47% and 42% SA/A; P < 0.01 for NIP survey
only).c Results are fully presented in Table 6.
Access to medicinesc
In both the NIP and PIP surveys, the majority
of respondents stated no diﬀerence in care
received from either NMP or doctor compared
with better care from the NMP or better care
from a doctor for getting ‘their prescription
more quickly’ (P < 0.01) and ‘how easy’ it was
to ‘get their medicines’ (P < 0.01; see Table 6).c
Table 4 Comparing care received from the independent prescriber and the doctor - Quality and safety of care
Pharmacist independent prescriber survey Pharmacist independent prescriber survey
N %
Comparisons
n %
Comparisons
All groups
P value
NIP vs. doctor
P value
All groups
P value
PIP vs. doctor
P value
I receive better quality care from the
Independent prescriber 17 12.7 <0.01 0.87 14 10.9 <0.01 <0.01
Doctor 18 13.4 42 32.8
No difference 99 73.9 72 56.3
I receive safer care from the
Independent prescriber 11 8.2 <0.01 <0.01 13 10.2 <0.01 <0.01
Doctor 28 20.9 43 33.6
No difference 95 70.9 72 56.3
P value reports on comparisons between (i) NIP (or PIP) vs. doctor vs. no difference: all groups (ii) the subgroup with strong preferences for a
prescriber: NIP (or PIP) vs. doctor.
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Table 5 Comparing care received from the independent prescriber and the doctor - Support for adherence
Nurse independent prescriber
survey
Pharmacist independent
prescriber survey
N of SA/A %
SA/A vs. SD/D
P value N of SA/A %
SA/A vs. SD/D
P value
I am happier with my medicines since being treated
by my independent prescriber
61 43.3 0.84 59 44.7 0.85
I am more likely to take my medicines when they
are prescribed by an independent prescriber
26 18.4 <0.01 28 21.2 <0.01
N %
All groups
P value
NIP vs. doctor
P value n %
All groups
P value
PIP vs. doctor
P value
If I have a concern about a new medicine I find it easier to raise it with
Independent prescriber 33 24.4 <0.01 0.35 42 33.3 0.68 0.67
Doctor 41 30.4 46 36.5
No difference 61 45.2 38 30.2
My condition / health is monitored better by the
Independent prescriber 37 28.0 <0.01 0.32 35 27.3 0.04 0.03
Doctor 29 22.0 56 43.8
No difference 66 50.0 37 28.9
I am better informed about my treatment by the
Independent prescriber 34 25.6 <0.01 1.00 37 28.7 0.05 0.05
Doctor 34 25.6 56 43.4
No difference 65 48.9 36 27.9
Nurse independent prescriber survey Pharmacist independent prescriber survey
N %
All groups
P value
NIP vs. doctor
P value N %
All groups
P value
PIP vs. doctor
P value
I am more likely to be asked about how I can fit medicines into my routine by the
Independent prescriber 33 24.4 <0.01 <0.01 30 24.2 <0.01 0.54
Doctor 15 11.1 35 28.2
No difference 87 64.4 59 47.6
I feel more able to ask questions about my medicines with the
Independent prescriber 37 27.6 <0.01 0.32 47 37.0 0.21 0.12
Doctor 29 21.6 33 26.0
No difference 68 50.7 47 37.0
I am more likely to be advised about non-drug treatments for my condition/s by the
Independent prescriber 28 21.2 <0.01 0.68 24 20.0 <0.01 0.15
Doctor 25 18.9 35 29.2
No difference 79 59.8 61 50.8
I am more likely to be told how a new medicine will help me by the
Independent prescriber 23 16.9 <0.01 0.02 37 29.8 0.53 0.28
Doctor 42 30.9 47 37.9
No difference 71 52.2 40 32.3
I am more likely to be told about the possible side effects of a new medicine by the
Independent prescriber 22 16.3 <0.01 0.02 44 34.4 0.88 0.66
Doctor 40 29.6 40 31.3
No difference 73 54.1 44 34.4
The 10 items reported in Table 5 were included in two separate sets of questions. The first set of questions (the first two items of the table)
were Likert-type scales, where the percentage and numbers SA/A were compared with those SD/D. The second set of questions (remaining 8
items) compared the services provided by their NIP or PIP and their doctor and reported on three separate options (independent prescriber,
doctor and no difference). P value reports on comparisons between (i) NIP (or PIP) vs. doctor vs. no difference: all groups; (ii) the subgroup
with strong preferences for a prescriber: NIP (or PIP) vs. doctor.
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Discussion
This study addressed patients’ perceptions and
experience of care by nurse and pharmacist
independent prescribers in general practices in
primary care in England. Overall, the ﬁndings
show that independent non-medical prescribing
was valued highly by patients and that gener-
ally there were few perceived diﬀerences in the
care received from respondents’ NMP and their
usual doctor. Patients’ reports on the presence
of key quality features of consultations with
NMPs provide evidence indicating an orienta-
tion towards producing good medicine man-
agement outcomes. Most patients did not
express a strong preference for receiving care
from a particular professional although there
was a small group of patients who expressed a
preference for the GP. There was some evi-
dence that patients of NIPs, who had a longer
therapeutic relationship than those of PIPs (for
whom independent prescribing was more
Table 6 Comparing care received from the independent prescriber and the doctor – control of condition, access to care and
medicines
Nurse independent prescriber survey
Pharmacist independent prescriber
survey
Number of SA/A %
SA/A vs. SD/D
P value Number of SA/A %
SA/A vs. SD/D
P value
Control of condition
My condition is controlled better
since being treated by my
independent prescriber
61 43.3 0.13 57 43.2 0.12
Being treated by my independent
prescriber has had no effect on my
condition
46 32.6 0.03 44 33.3 0.27
Access to care
I get longer appointments with my
independent prescriber than my
doctor
54 38.3 0.57 52 39.4 0.63
Since being treated by my
independent prescriber I have the
same number of appointments for
my condition as previously when
treatment by my doctor
67 47.5 0.01 56 42.4 0.38
Access to medicines n %
All groups
P value
NIP vs. doctor
P value n %
All groups
P value
PIP vs. doctor
P value
I can get my prescription more quickly from the
Independent prescriber 29 21.6 <0.01 0.15 37 28.7 <0.01 0.21
Doctor 19 14.2 27 20.9
No difference 86 64.2 65 50.4
Generally, getting my medicines is easier from the
Independent prescriber 27 20.1 <0.01 0.39 33 25.8 <0.01 0.90
Doctor 21 15.7 32 25.0
No difference 86 64.2 63 49.2
The 6 items reported in Table 6 were included in two separate sets of questions. The first set of questions (the first four items of the table
reporting on control of condition and access to care) were Likert-type scales, where the percentage and numbers SA/A were compared with
those SD/D. The second set of questions (remaining two items on access to medicines) compared the services provided by their NIP or PIP
and their doctor, and reported on three separate options (independent prescriber, doctor and no difference). P value reports on comparisons
between (i) NIP (or PIP) vs. doctor vs. no difference: all groups; (ii) the subgroup with strong preferences for a prescriber: NIP (or PIP) vs.
doctor.
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recently introduced), generally tended to give
more positive ratings.
Respondents prescribed for by NIPs or PIPs
had generally comparable characteristics,
although there were more female respondents
for the NIP survey. All patients had consulted
with a NIP or PIP in the last 12 months and,
although there were diﬀerences in the number
of times each patient had done so, this is typi-
cal of consultation patterns in primary care.
Most patients reported at least two previous
consultations with their NMP, with patients of
prescribing nurses reporting higher numbers.
This proﬁle is unsurprising as nurses in general
practice have been involved in the monitoring
and management of long-term conditions for
many years prior to the extension of indepen-
dent prescribing. Pharmacists’ involvement has
been more recent, and this was reﬂected in the
experience of the patients in the survey. These
diﬀering experiences may partly explain the
variation in missing data for some questions
and the possibility that the small number who
did not respond may not have been able to
answer all of the questions if they had seen the
NMP only once.
Patients’ consultations were mainly for diabe-
tes and respiratory problems in the NIP sample
and for hypertension or secondary prevention
of heart problems in the PIP sample. For these
particular conditions, although we did not ask
directly about disease measurements, we would
argue that it is likely that patients would have
been in a position to comment on how well
controlled their condition was. For asymptom-
atic conditions such as hypertension primary
care quality standards require regular measure-
ment and recording of values, at which point
usual practice would be that the patient is made
aware of whether changes in treatment are nec-
essary. There is little published research in this
area but in a survey of patients whose hyperten-
sion was managed by a pharmacist supplemen-
tary prescriber almost two-thirds of the
respondents said that the standard of care they
received in the management of their hyperten-
sion was higher than previously and only 2%
said it was worse.19
Patients’ responses, in the majority of cases,
aﬃrmed the presence of key consultation char-
acteristics highlighted in national guidelines as
underpinning elements of support for adher-
ence20 including establishment of rapport, being
told as much about their medicines as they
wanted and feeling that the prescriber under-
stood their point of view. Almost two-thirds
said they were involved in decisions about their
medicines, conﬁrming ﬁndings from other
research.21 Most classiﬁed their relationship
with the NMP as good and had conﬁdence in
them. These ﬁndings echo those of previous sur-
veys of patients of pharmacist and nurse supple-
mentary prescribers.8,19,22 and also suggest
congruence with national guidelines on adher-
ence.20 In comparison with the overall positive
trends reported here, about one-quarter of the
sample agreed or strongly agreed that ‘some
things about my consultation could have been
better’. It would be interesting to explore this
further in future research on patients’ views.
Eliciting patients’ beliefs about their medi-
cines is known to be an important element of
supporting adherence. Here, results were more
mixed and around 40% of respondents in both
surveys disagreed that this was the case. There
may be a number of reasons for this (such as
patients having been asked this at a previous
consultation). However, this ﬁnding is consis-
tent with other research on health profession-
als’ communication in consultations which
indicates that beliefs about the necessity of,
and concerns about, medicines are not always
explored and therefore might indicate a need
for further research and/or practice develop-
ment in this area.23,24 There is evidence from a
small qualitative study with mental health ser-
vices users being cared for by nurse prescribers
that information about why medication use
may be beneﬁcial was an unmet need.14
Overall patients did not express a strong pref-
erence for care received from either non-medical
or medical prescriber, including access to care
and their medicines, control of condition,
support for adherence, quality and safety of
care. Among the subgroups of patients express-
ing a preference for a particular professional,
© 2013 John Wiley & Sons Ltd
Health Expectations, 18, pp.1241–1255
Survey of patients’ experiences and perceptions of care, M Tinelli et al. 1251
responses to a small number of statements
showed a trend to rate the doctor more highly.
This was the case for safety of care among
patients of both NIPs and PIPs and quality of
care for patients of PIPs. Previous research with
patients of nurse and pharmacist supplementary
prescribers found that they were perceived as
having specialist expertise in the speciﬁc clinical
areas in which they prescribed and doctors were
viewed as having a more generalized exper-
tise.6,25 Our results support these ﬁndings by
conﬁrming high levels of acceptance of care of
long-term conditions from independent nurse
and pharmacist prescribers.
In a theoretical study of patients’ preferences
for pharmacist supplementary prescribing,
patients valued the NMP service, but were
reported to be ‘resistant to change’.26 More
recently, from the views of pharmacy clients
with no experience of pharmacist prescribing
services, it emerged that most respondents
trusted pharmacists adopting an expanded role
in prescribing, although the majority supported
this change only if the diagnosis was under-
taken by a doctor.27 Findings from other
research with patients and their supplementary
NMPs in general practices found that patients
had few concerns about long-term conditions
being managed by NMPs, but many viewed
responsibility for acute health problems as
remaining with their GP.28 There is also some
evidence that patients’ acceptance of non-medi-
cal prescribing has increased over time and
with their experience. The percentage of
patients of PIPs agreeing that given a choice,
they would prefer to be treated by a doctor
was 65%11 in a study and 43% in a 2010 sur-
vey by the same researchers.11,13 Further
research should investigate any diﬀerence in
patient characteristics, and the condition they
were consulting for when comparing subgroups
of respondents stating diﬀerent preferences for
choice of health-care professionals.
Our study raises questions about possible
diﬀerences in the nature of the relationship
between NIPs and their patients compared
with PIPs and their patients. For some ques-
tions, patients of NIPs generally tended to give
more positive ratings than those of PIPs. Given
that direct experience of consultations with
NMPs was greater in the NIP group, it is likely
that the relationship between NIP and patient
had been built up over a period of time, per-
haps leading to greater experience and trust in
their care. In a qualitative study with 18
patients of medical and NMPs in primary and
secondary care, it was reported that although
the expert knowledge of pharmacist prescribers
about medicines was valued, ‘nurses were
highly regarded, accepted and preferred as pre-
scribers with few concerns’.29 In contrast, a
survey of members of the public found the pro-
portion saying they would be comfortable with
prescribing by pharmacists was higher than
that for nurses.12
Previous studies have found that patients
reported having longer appointments with
NMPs and that this was viewed positively.4,6–
8,13 In the current study, fewer than half of
patients of both NIPs and PIPs had longer
appointments with their NMP compared with
their doctor and around a quarter said they
wished it had been possible to spend more time
in their most recent consultation with the
NMP. These ﬁndings may reﬂect a change over
time in the length of appointments of NMPs
or that even if appointments are longer than
for typical GP consultations, there is still a
substantial minority of patients who wish for
more time. Data from elsewhere in our evalua-
tion showed that length of appointment had no
observable impact on patient satisfaction with
their prescriber, whilst attributes relating to
patient–professional interaction did impact on
patients’ choices in the management of diag-
nosed hypertension.30
In contrast to the ﬁndings of earlier studies
of nurse prescribing, our respondents did not
report any signiﬁcant diﬀerences in access to
medicines from NMPs and medical prescribers
either in terms of the ease of getting prescrip-
tions or speed of getting prescriptions. Else-
where in our evaluation, NIPs and PIPs
reported that the number of available appoint-
ments in the practice was higher with NMP
and the ﬁndings of the current study suggest
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that this increased capacity may now be fully
utilized. Some commentators on NMP were
concerned that care may become fragmented
and that patients might have to attend the
practice for more appointments. Our ﬁndings
in this regard are mixed, and there is no signiﬁ-
cant agreement that their total number of
appointments had remained the same.
Our research conﬁrms that independent pre-
scribing by pharmacists and nurses is well
received by patients and that the expanded
range of medicines now prescribed by NIPs
and the introduction of PIPs has not detracted
from the overall picture of patient satisfaction
with NMPs. Furthermore, when measuring
patients’ preferences for PIP services for man-
aging common existing long-term conditions,
we have also reported that the PIP service is
valued by patients as an alternative to prescrib-
ing by a doctor in primary care and therefore
represents an acceptable form of service deliv-
ery when promoting patient-centred policy
developments.30
When interpreting the results of the study
some strengths and limitations need to be con-
sidered. This study is one of the largest surveys
of patients of both NIPs and PIPs to date and
the ﬁrst to have focused primarily on the man-
agement of long-term conditions and with
responses from almost 300 patients of 10 NIPs
and PIPs. To our knowledge, it was also the
ﬁrst survey conducted with patients of PIPs
and, for NIPs, the ﬁrst since the 2006 changes
enabled prescribing of a wider range of medi-
cines. A potential limitation is that there was
no existing validated questionnaire so where
possible we used questions drawn from previ-
ous surveys and we piloted new questions to
cover areas not addressed in prior studies. The
questionnaire focused on patients’ direct expe-
rience of consultations with NMPs as evidence
suggests that measures addressing only satisfac-
tion are insuﬃciently discriminating.31 Patients
were identiﬁed and contacted independently
from their NMPs, reducing potential selection
bias compared with other studies where the
practitioner nominated patients to receive a
questionnaire. Researcher access to patient
contact details was not granted at several sites,
and thus, a single mailing was used. This is
likely to be the main reason why response rates
were not as high as would have been desirable,
with the mean response rate 30%. Demo-
graphic data for the total population were not
available. Therefore, it is possible that the
respondents were not representative of the total
population. The study focused on the condi-
tions in which NIPs and PIPs reported pre-
scribing most frequently; hence, the ﬁndings
cannot be applied to all long-term conditions.
The study has generated evidence from
patients’ perspectives about how well their con-
dition was controlled before and after the
involvement of the NMP. However, it was not
possible to collect clinical data for comparison,
and this is an area for future research. Patients
were asked about their experience of either a
NIP or a PIP, and most patients are likely to
have only experienced care from one of these.
Therefore, it was not possible to ask patients
to make comparisons between care from a NIP
and a PIP. The sample sizes for the two data-
sets did not allow testing for diﬀerences
according to all patient characteristics, future
research can address this. An added caveat is
that the present evaluation is based on self-
reported data, and studies focused on evaluat-
ing NMP impact on clinical and health-related
outcomes as well as patient experience data
collected in randomized controlled trial condi-
tions are now required.32
Conclusions
Independent prescribing by nurses and phar-
macists for long-term conditions was well
received by patients who reported having
established good relationships with their NMP
and having conﬁdence in the care provided.
Most patients did not express a strong prefer-
ence for care provided by either their non-med-
ical or medical prescribers with a small
subgroup preferring to receive care from their
doctor. These ﬁndings support the further
implementation of non-medical prescribing to
support patients with long-term conditions.
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